Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reaching 90% Target of HIV Viral Suppression: The Role of Point-of-Care Viral Load Monitoring in Resource-Constrained Settings in Nigeria

NCT03533868 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.

NCT NCT03533868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reaching 90% Target of HIV Viral Suppression: The Role of Point-of-Care Viral Load Monitoring in Resource-Constrained Settings in Nigeria
Lead sponsor
Harvard School of Public Health (HSPH)
Phase
Not applicable
Overall status
Completed
Start date
April 9, 2018
Completion date
February 28, 2021
Enrollment
543 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids